UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report:

July 8, 2019

 

ProtoKinetix, Incorporated

(Exact name of registrant as specified in its charter)

 

Nevada   000-32917   94-3355026
State of   Commission   IRS Employer
Incorporation   File Number   Identification No.

 

412 Mulberry Street

Marietta, OH 45750

Address of principal executive offices

 

304-299-5070

Telephone number, including

Area code

 

 

Former name or former address if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

 

  [  ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  [  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  [  ] Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  [  ] Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A        

 

 

 

 
 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

On July 15, 2019, the Board of Directors of ProtoKinetix, Incorporated (the “Company”), amended the Amended 2017 Stock Option and Stock Bonus Plan (the “2017 Plan”) to increase the aggregate number of shares that may be issued under the 2017 Plan from 50,000,000 to 89,700,000 shares subject to adjustment as provided in the 2017 Plan.

 

As of July 15, 2019, 76,700,000 options are outstanding under the 2017 Plan.

 

Also on July 15, 2019, the Board of Directors of the Company (the “Board”) canceled a total of 16,000,000 options previously granted to its CEO, a director, and a consultant and granted a total of 16,000,000 new options under the 2017 Plan at an exercise price of $0.26 per share as follows: Clarence Smith, President, CEO & Director (an option to purchase 5,000,000 shares); Edward McDonough, Director (an option to purchase 1,000,000 shares); and Grant Young, a consultant (options to purchase 10,000,000 shares). Twenty-five percent of the shares vest on October 13, 2019 and 25% vest every three months thereafter. The options expire on July 14, 2024. Prior to a change in control of the Company, the vesting schedule of the option shall immediately accelerate so that the option is fully vested and available for exercise.

 

In connection with the continued service of certain directors, officers and consultants, on July 15, 2019 the Board granted options pursuant to the 2017 Plan to acquire shares of common stock of the Company at an exercise price of $0.26 per share as follows: Mr. Smith (an option to purchase 5,000,000 shares); Mr. McDonough (an option to purchase 2,000,000 shares); Michael Guzzetta, CFO (an option to purchase 4,000,000 shares); and Mr. Young (options to purchase 5,000,000 shares). Twenty-five percent of the shares vest on October 13, 2019 and 25% vest every three months thereafter. The options expire on July 14, 2024. Prior to a change in control of the Company, the vesting schedule of the option shall immediately accelerate so that the option is fully vested and available for exercise. The Company also issued an option under the 2017 Plan to a consultant to acquire 500,000 shares at an exercise price of $0.26 per share. The option is identical to the others issued by the Board except that 250,000 shares vest on October 13, 2019 and 250,000 vest three months thereafter.

 

For these grants of options, no solicitation was used and the Company relied on the exemption from registration available under Section 4(a)(2) of the Securities Act of 1933, as amended (the “1933 Act”) and/or Rule 506(b) of Regulation D promulgated under the 1933 Act with respect to transactions by an issuer not involving any public offering.  No commissions were paid in connection with these issuances of securities.

 

 

 

 
 

 

 

Item 5.05 Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics.

 

On July 8, 2019, the Board adopted a new Code of Business Conduct and Ethics and Whistleblower Policy (“Code of Ethics”) which replaced in its entirety the Company’s prior code of ethics. The Code of Ethics applies to all directors, officers, employees and consultants of the Company and amends and restates the Company’s prior code of ethics to update certain provisions for business and regulatory developments and to provide additional guidance and greater detail on certain issues such as conflicts of interest, reporting illegal or unethical behavior, confidentiality and use of the Company’s assets, and hedging of Company securities.

 

The Board also approved an insider trading policy, related party transactions policy, and policy on trading blackout periods, benefit plans and SEC reporting.

The above description of the Code of Ethics does not purport to be complete and is qualified in its entirety by reference to the full text of the Code of Ethics, which is filed herewith as Exhibit 14.1. A copy of the Code of Ethics and other corporate governance documents are available on the Company’s website at www.protokinetix.com.

Item 9.01 Financial Statements and Exhibits

 

(d) Exhibits

 

4.1 Amendment to Amended 2017 Stock Option and Stock Bonus Plan as approved on July 15, 2019
14.1 Code of Business Conduct and Ethics and Whistleblower Policy as approved on July 8, 2019

 

 

 
 

 

 

     
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 16th day of July 2019.

 

  ProtoKinetix, Incorporated
   
  By: /s/Clarence E. Smith
    Clarence E. Smith, President & CEO

 

     
 

  

 

 

 

Exhibit 4.1

 

 

 

 

AMENDMENT TO

ProtoKinetix, Incorporated

Amended 2017 Stock Option and Stock Bonus PLAN

 

Section 5(a) of the Plan is hereby amended as follows:

 

Section 5. Stock Reserved .

(a)                 The stock subject to Awards hereunder shall be shares of Common Stock. Such shares, in whole or in part, may be authorized but unissued shares or shares that shall have been or that may be reacquired by the Corporation. The aggregate number of shares of Common Stock that may be issued under the Plan is 89,700,000, subject to adjustment as provided in Section 8(i) hereof. No adjustment shall decrease the number of shares issuable pursuant to the Plan below the number of shares of Common Stock that have been issued pursuant to the Plan plus the number of shares of Common Stock underlying outstanding awards.

 

 

 

Exhibit 14.1

 

 

protokinetix, Incorporated

 

CODE OF BUSINESS CONDUCT AND ETHICS

AND WHISTLEBLOWER POLICY

 

Adopted by the Board of Directors on July 8, 2019

 

Introduction

ProtoKinetix, Incorporated (the “Company”) is committed to the highest standards of legal and ethical business conduct. This Code of Business Conduct and Ethics and Whistleblower Policy (the “Code”) summarizes the legal, ethical and regulatory standards that the Company must follow and is a reminder to our directors, officers and employees of the seriousness of that commitment. Compliance with this Code and high standards of business conduct is mandatory for every director, officer, employee, and consultant of the Company and its subsidiaries. This Code is intended to comply with the requirements of SEC Regulation S-K, Item 406 as well as SEC Rule 10A-3(b)(3) and NASDAQ Listing Rule 5610.

Our business is becoming increasingly complex in terms of the geographies in which we function and the laws with which we must comply. To help our directors, officers, consultants and employees understand what is expected of them and to carry out their responsibilities, we have created this Code. Our Compliance Officer will have the primary responsibility of overseeing adherence to the Code. Michael R. Guzzetta has been appointed as our Compliance Officer. You should address any questions to our Compliance Officer and also, if appropriate, notify the Company’s independent director.

This Code is not intended to be a comprehensive guide to all of our policies or to all your responsibilities under law or regulation. It provides general parameters to help you resolve the ethical and legal issues you encounter in conducting our business. Think of this Code as a guideline, or a minimum requirement, that must always be followed. If you have any questions about anything in the Code or appropriate actions in light of the Code, you may contact the Company’s Compliance Officer.

This Code should be read in conjunction with our other corporate policies, including our Insider Trading Policy and Related Party Transactions Policy. If you have questions about this Code, other Company policies, or how to comply with the law in a certain situation, it is important that you immediately bring your questions to the Compliance Officer or any of the Company’s executive officers. If you are in or observe a situation that you believe may violate or lead to a violation of this Code, you should refer to Section D of this Code for guidance on how to report questionable behavior.

 

Anyone who violates the standards of this Code will be subject to disciplinary action. Such action may include immediate termination of employment.

For the purpose of this Code the term “the Company” should be interpreted to apply to ProtoKinetix, Incorporated, (a Nevada corporation) and the terms “we,” “our,” “us” and similar terms refer to the Company and the terms “you” and “your” refer to the directors, officers, employees, and consultants of the Company.

1  
 

 

 

A.        Compliance with All Laws, Rules and Regulations

 

The Company requires that all of its directors, officers, employees, and consultants strictly adhere to all applicable local, state and federal laws. If you have questions about what laws we are subject to, or about how to comply with certain laws, it is important that you alert an officer of the Company to your question. We rely on you not only to act ethically, but also to assist your fellow employees, consultants and management in following the law.

 

When appropriate, the Company will provide information and training to promote compliance with laws, rules and regulations, including insider-trading laws.

 

B.        Ethical Conduct, Conflicts of Interest and Related Party Transactions

 

The Company’s employees, consultants, officers and directors are expected to make or participate in business decisions and actions based on the best interests of the Company as a whole, and not based on personal relationships or personal gain. As we define it, a “conflict of interest” exists when a person’s private interest interferes in any way with the interest of the Company, or even when a private interest creates an appearance of impropriety. A conflict situation can arise when you have interests that make it difficult for you to perform your work objectively, or when a director, officer, employee, or consultant receives improper personal benefits as a result of his or her position with the Company.

 

It is almost always a conflict of interest for a Company employee or consultant to work simultaneously for a competitor, customer or supplier.

 

It is also almost always a conflict of interest for a full-time Company employee to have a second job elsewhere, whether or not with a competitor, customer or supplier unless you have notified the president of Company of the second job, and the president approves.

 

You should avoid any relationship that would cause a conflict of interest with your duties and responsibilities at the Company. All directors, officers, employees, and consultants are expected to disclose to management any situations that may involve inappropriate or improper conflicts of interests affecting them personally or affecting other directors, officers, employees, and consultants or those with whom we conduct business.

 

Members of the Company’s Board of Directors have a special responsibility to our company and to our stockholders. To avoid conflicts of interest, directors are required to disclose to their fellow directors any personal interest they may have in a transaction being considered by the Board of Directors and, when appropriate, to recuse themselves from any decision involving a conflict of interest. Unless and until such responsibility is delegated to a committee of the Board of Directors, the Board of Directors as a whole is charged with reviewing and approving all related party transactions and potential conflict of interest situations. Waivers of a conflict of interest or this Code involving executive officers and directors require approval by the Board of Directors. Any such waiver will be disclosed to our stockholders within four business days, along with the reasons for the waiver, through the filing of a Form 8-K.

 

2  
 

 

 

 

Any discovery of a potential or existing conflict of interest should be immediately disclosed to management in accordance with the procedures set forth in Section D of this Code.

 

C.        Our Commitment to Full, Fair, Accurate, Timely and Plain English Disclosure

 

As a public company, it is critical that the Company’s filings with the Securities and Exchange Commission (the “SEC”) be complete, timely and accurate in all material respects. At the Company, all our employees, consultants, officers and directors are charged with the responsibility of providing management with accurate and complete information to assure we are complying with our public disclosure requirements and our commitment to our stockholders.

 

Commensurate with these special duties, all executive officers, directors, consultants and employees each agree that he or she will:

 

1. Act honestly and ethically in the performance of their duties at the Company, avoiding actual or apparent conflicts of interest in personal and professional relationships.

 

2. Provide information that is accurate, complete, objective, relevant, timely and understandable to ensure full, fair, accurate, timely and understandable disclosure in reports and documents filed with or submitted to the SEC or used in other public communications by the Company.

 

3. Comply with applicable rules and regulations of federal, state, provincial, local and overseas governments, as well as those of other appropriate private and public regulatory agencies that affect the conduct of the Company’s business and the Company’s financial reporting.

 

4. Act in good faith, responsibly, with due care, competence and diligence, without misrepresenting material facts or allowing one’s independent judgment to be subordinated.

 

5. Respect the confidentiality of information acquired in the course of one’s work, except when authorized or otherwise legally obligated to disclose such information. Further, confidential information acquired in the course of performing one’s duties for the Company will not be used for personal advantage.

 

6. Share knowledge and maintain skills relevant to carrying out the member’s duties within the Company.

 

7. Proactively promote and set an example of ethical behavior as a responsible partner among peers and colleagues in the work environment and community.

 

3  
 

 

 

 

8. Achieve responsible use of and control over all assets and resources of the Company to which they are entrusted.

 

9. Promptly bring to the attention of our Compliance Officer any information concerning (a) any conduct believed to be a violation of law or business ethics, or this Code, including any transaction or relationship that reasonably could be expected to give rise to such a conflict, (b) significant deficiencies in the design or operation of internal controls which could adversely affect the Company’s ability to record, process, summarize and report financial data or (c) any fraud, whether or not material, that involves management or other employees or consultants who have a significant role in the Company’s financial reporting, disclosures or internal controls.

 

D.        The Company’s Enforcement Mechanisms and Open Door Policy on Reporting Violations

 

Our employees and consultants are encouraged to talk to senior management about observed illegal or unethical behavior and to ask questions when in doubt as to how to comply with this Code, our policies, and the law. Any person who has complaints or concerns about the Company’s accounting, internal accounting controls or auditing matters, who becomes aware of questionable accounting or auditing matters, or who becomes aware of any violation by any person of law or Company policies, is strongly encouraged to report such matters to the Compliance Officer.

 

To protect persons reporting questionable behavior, it is the policy of the Company not to allow retaliation for reports of misconduct by others made in good faith by our employees or consultants. Further, employees, consultants, officers and directors, are expected to cooperate and be forthcoming with information during an internal or regulatory investigation of misconduct. Any employee, consultant, officer or director may submit a good faith concern regarding questionable accounting or auditing matters without fear of dismissal or retaliation of any kind.

 

In order to facilitate a complete investigation, employees, consultants, directors and officers should be prepared to provide as many details as possible, including a description of the questionable practice or behavior, the names of any persons involved, the names of possible witnesses, dates, times, places and any other available details. The Company encourages all employees and consultants with complaints or concerns to come forward with information and prohibits retaliation against employees and consultants raising concerns. Nonetheless, if an employee or consultant feels more comfortable doing so, reports may be made confidentially and/or anonymously to the Compliance Officer or to the Board of Directors.

 

At the Company, we all work as a team to ensure prompt and consistent action against violations of this Code or applicable laws. To establish clear and objective standards for compliance and a fair process by which to determine violations, this procedure should be followed:

 

1. Gather Facts . In the event some behavior or action raises a question as to your own or someone else’s compliance with this Code, the first step is to collect all available facts, as time permits.

 

 

4  
 

 

 

2. Clarify the Circumstances at Issue . In most situations, there is shared responsibility. It may help to get others involved to discuss a perceived problem.

 

3. Discuss the Problem with Management . This is your most basic responsibility. If you have a concern, discuss it with our Compliance Officer.

 

4. You May Report Violations in Confidence Without Fear of Retaliation . If the situation requires that your identity be kept secret, your anonymity will be protected to the extent permitted by law.

 

5. Ask First, Then Act . If you are unsure of what to do in any situation, seek guidance before you act.

 

Given the broad scope of this Code, violations may occur in differing degrees. In most cases, management is charged with enforcement of this Code. In other cases, a committee of the Board of Directors may be involved. To ensure consistency, management will take the following steps when it receives information that there has been a violation of this Code and/or the law:

 

Reports Related to Financial Practices : Complaints, questions or concerns related to our financial practices should be addressed to our Compliance Officer.

 

Questions Related to General Business Practices : If after reviewing a complaint or question, management reasonably believes a material violation of this Code may have occurred, management will either begin an internal investigation, or where appropriate, engage the services of an independent, outside professional to conduct an investigation. If the results of an investigation indicate that a violation of the Code and/or the law has occurred, management will take appropriate disciplinary action. Such disciplinary action, which may include termination of employment, will take into account the seriousness of the violation, whether the conduct was willful or inadvertent, applicable laws related to employee rights, and general industry standards.

 

E.       CONFIDENTIALITY AND CORPORATE ASSETS

Our directors, officers, consultants and employees are entrusted with our confidential information and with the confidential information of our business partners. This information may include: (1) technical or other information about current and future projects or endeavors; (2) business or marketing plans or projections; (3) earnings and other internal financial data; (4) personnel information; (5) lists of current, past and potential business partners; and (6) other non-public information that, if disclosed, might be of use to our competitors, or harmful to our business partners. This information is our property, or the property of our business partners, and in many cases was developed at great expense. Unless authorized by written approval or required by applicable law, our directors, officers, consultants and employees shall not:

1. Discuss confidential information with or in the presence of any unauthorized persons, including family members and friends.

 

 

5  
 

 

 

 

2.

Use confidential information for illegitimate business purposes or for personal gain.

 

3. Disclose confidential information to unauthorized third parties.

 

4. Use Company property or resources for any personal benefit or the personal benefit of anyone else. The Company’s property includes, without limitation, the Company’s internet, email and voicemail services, which should be used only for business related activities, and which may be monitored by the Company at any time without notice.

 

F.       HEDGING OF THE COMPANY’S SECURITIES

Section 955 of the Dodd-Frank Wall Street Reform and Consumer Protection Act added Section 14(j) to the Securities Exchange Act of 1934 which requires each issuer (including the Company) to disclose whether any employee, consultant, officer or member of the Board of Directors, or any designee of any employee, consultant, officer or board member, is permitted to purchase hedges on the Company’s securities—that is, financial instruments that are designed to hedge or offset against any decrease in the market price for the Company’s securities. The Board of Directors has concluded that it is inappropriate for employees, consultants, officers or members of the Board of Directors, or any designee of such persons, to purchase hedges.

 

Acknowledgement . Each employee, consultant, officer, and director of the Company must acknowledge that he or she has received a copy of this Code of Ethics and has reviewed this Code of Ethics. This acknowledgement will be maintained in the Company’s files.

 

 

 

 

6